Davis Brady 4
4 · CHAMPIONS ONCOLOGY, INC. · Filed Apr 1, 2024
Insider Transaction Report
Form 4
Davis Brady
President
Transactions
- Award
Option to purchase Common Stock
2023-10-09$6.50/sh+68,000$442,000→ 210,500 totalExercise: $6.50Exp: 2033-10-09→ Common Stock (68,000 underlying) - Award
Option to purchase Common Stock
2023-10-09$6.50/sh+135,000$877,500→ 135,000 totalExercise: $6.50Exp: 2033-10-09→ Common Stock (135,000 underlying) - Award
Option to purchase Common Stock
2023-10-09$6.50/sh+7,500$48,750→ 142,500 totalExercise: $6.50Exp: 2033-10-09→ Common Stock (7,500 underlying)
Footnotes (3)
- [F1]The options vest over a four year period and are exercisable over a ten year period, with vesting to occur on October 9, 2024, October 9, 2025, October 9, 2026 and October 9, 2027, respectively.
- [F2]The options vest fully (100%) on the one year anniversary of the date of grant and are exercisable over a ten year period, with vesting to occur on October 9, 2024.
- [F3]The options vest over a four year period starting from the one year anniversary of the achievement of specific performance criteria and are exercisable over a ten year period.